Using Red Djulis Products Can Improve Skin Conditions

NCT ID: NCT04733859

Last Updated: 2021-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-01

Study Completion Date

2018-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis: Using red djulis products can improve skin conditions

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

placebo group

subjects drank 50 ml , 1 bottle a day for 8 week

Group Type PLACEBO_COMPARATOR

placebo group

Intervention Type DIETARY_SUPPLEMENT

subjects drank 50 ml , 1 bottle a day for 8 week

red djulis drinks

subjects drank 50 ml , 1 bottle a day for 8 week

Group Type EXPERIMENTAL

red djulis drinks

Intervention Type DIETARY_SUPPLEMENT

subjects drank 50 ml , 1 bottle a day for 8 week

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

placebo group

subjects drank 50 ml , 1 bottle a day for 8 week

Intervention Type DIETARY_SUPPLEMENT

red djulis drinks

subjects drank 50 ml , 1 bottle a day for 8 week

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Dry skin
2. Rough skin
3. Large pores
4. Dark yellow complexion
5. Sagging skin

Exclusion Criteria

1. Skin disorders
2. Liver diseases
3. Kidney diseases
4. Allergy to cosmetics, drugs, or foods
5. Pregnant and lactating women
6. People who had any cosmetic procedures before 4 weeks of the study
7. Area of facial spot over 3 cm2
8. Vegan
9. People who took collagen supplements in the past 3 months.
Minimum Eligible Age

20 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TCI Co., Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chia-Hua Liang, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Chia Nan University of Pharmacy & Science

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research & Design Center, TCI CO., Ltd

Taipei, Neipu Township, Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20180905RED

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Anti-Redness Clinical Study
NCT07200492 COMPLETED NA
Inducing Redness Clinical Study
NCT07179263 COMPLETED NA